Impact BioMedical, Inc.
Market Cap
56M
Short interest (May 15)
0.7%
Net Short (Jun 03 ): 0.0%
Borrow Fee
21.80%
↓ 40.5%
Available Shares
900K
↑ 9.8%
Price Chart
Company Overview
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.